Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Clobetasol Propionate and Photobiomodulation in Pemphigus Vulgaris
NCT07641725Recruiting
- Sponsor
- Damascus University
- Start
- Nov 2025
- Primary completion
- Sep 2026
- Countries
- 1
01
Overview
Randomised trial of clobetasol in pemphigus vulgaris (PV) (3 arms), sponsored by Damascus University. Primary endpoints: Pemphigus Disease Area Index at 90 days, Oral Disease Severity Score at 90 days and 2 more. Started Nov 2025; status: recruiting.
02
Drugs
clobetasol
03
Conditions
pemphigus vulgaris (PV)
Beyond the preview
Go deeper on NCT07641725.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07641725.